MedTech Europe’s position on the Regulation on Standards of quality and safety for substances of human origin intended for human application

MedTech Europe welcomes the Proposal for a Regulation on standards of quality and safety for substances of human origin intended for human application adopted by the European Commission in July 2022. The medical technology industry makes a clear contribution to raising the bar on the safety of substances of human origin (SoHO) all along the process, from donation to patient care and follow up.